Font Size: a A A
Keyword [PD-1/PD-L1 inhibitors]
Result: 21 - 40 | Page: 2 of 3
21. Echocardiographic Evaluation Of The Effects Of PD-1/PD-L1 Inhibitors On Left Ventricular Systolic Function In Cancer Patients
22. Evaluation Of The Effects Of PD-1/PD-L1 Inhibitors On Right Ventricular Function Using Echocardiography
23. Efficacy And Safety Of PD-1/PD-L1 Inhibitors Versus Chemotherapy In Second-line Treatment Of Advanced Esophageal Cancer:A Meta-Analysis Of Randomized Controlled Trials
24. A Meta-analysis Of The Efficacy And Safety Of PD-1/PD-L1 Inhibitors In The Treatment Of Advanced Gastric Cancer
25. Research Progress Of PD-1/PD-L1 Inhibitors In Combined Therapy In Advanced Colorectal Cancer
26. PD-1/PD-L1 Inhibitors Vs.chemotherapy For Previously Treated Advanced Gastroesophageal Cancer:A Meta-analysis Of Randomized Controlled Trials
27. Efficacy And Safety Of PD-1/PD-L1 Inhibitors Plus Chemotherapy For Triple Negative Breast Cancer:A Systematic Review And Meta-analysis
28. Evaluation Of PD-1/PD-L1 Inhibitor Combination Therapy Regimens In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma:A Network Meta-analysis
29. Molecular Simulations Of PD-1/PD-L1 Complex And De Novo Molecular Design Of Small Chemical Inhibitors
30. Design,Synthesis And Biological Activity Evaluation Of Small Molecule PD-1/PD-L1 Inhibitors Of Novel Resorcinol Dibenzyl Ether Analogues
31. Safety And Efficacy Of PD-1/PD-L1 Inhibitors In Patients With Malignant Tumors Associated With Hepatitis Virus Infection In A Real World Study
32. Efficacy And Safety Of PD-1/PD-L1 Inhibitors In Advanced Solid Tumors
33. Assessment And Prediction Of PD-1/PD-L1 Inhibitors Associated Early Cardiotoxicity In Patients With Lung Cancer Using Cardiac Magnetic Resonance
34. The Association Between BIM Deletion And Therapeutic Efficacy Of Osimertinib、PD-1/PD-L1 Inhibitors In NSCLC
35. Efficacy And Safety Of PD-1/PD-L1 Inhibitors Combinationtherapy In Advanced Colorectal Cancer:A Meta Analysis
36. Correlation Analysis Between HBsAg/HBV DNA And Prognosis Of Patients With HBV Related Hepatocellular Carcinoma Treated With PD-1/PD-L1 Inhibitors
37. Meta-analysis Of Clinical Efficacy For PD-1/PD-L1 Inhibitors In Elderly Patients With Advanced Non-small Cell Lung Cancer
38. Prognostic Significance Of NLR, PLR And Lymphocyte Subsets For First-line PD-1/PD-L1 Inhibitors In The Treatment Of Extensive Stage-small Cell Lung Cancer
39. Efficacy And Safety Of PD-1/PD-L1 Inhibitors Combined With Lenvatinib As First-line Treatment For Patients With Advanced Biliary Tract Carcinoma Who Are Intolerant To Or Refuse Chemotherapy
40. Meta-analysis Of The Influence Of Concomitant Gastric Acid Suppressants Use On The Survival Of Patients With Non-small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors
  <<First  <Prev  Next>  Last>>  Jump to